Understanding epigenetics - The potential rationale for BET inhibition in management of cardiovascular disease.
Topic:
Secondary Prevention
Speaker:
Doctor J. Plutzky (Boston, US)
Organised by PACE-CME, Physicians' Academy for Cardiovascular Education, supported with an educational grant from Resverlogix
Event:
ESC Congress 2018
Congress Presentation
About the speaker
Doctor Jorge Plutzky
Brigham and Women's Hospital, Boston (United States of America)
5
presentations
0
follower
4 more presentations in this session
The real residual risk in patients with cardiovascular disease and diabetes: the promise of epigenetics.
Speaker: Professor E. Stroes (Amsterdam, NL)
A clinical view on BET inhibition in targeting residual risk in cardiovascular disease and diabetes.
Speaker: Professor K. Ray (London, GB)
Discussion and summary - LDL-c: done deal, next epigenetics? .
Speaker: Professor U. Laufs (Leipzig, DE)
Access the full session
LDL-c: done deal, next epigenetics? (EBAC Accredited)
Speakers:
Doctor J. Plutzky, Professor U. Laufs, Professor E. Stroes, Professor K. Ray, Professor U. Laufs
About the event
